XML 15 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Income Statement [Abstract]        
Revenues $ 14,933 $ 27,148 $ 34,904 $ 59,000
Cost of revenues 9,917 22,107 34,103 50,992
Gross margin 5,016 5,041 801 8,008
Operating expenses:        
Research and development 3,023 2,985 8,690 8,804
Selling, general and administrative 5,486 6,077 16,964 19,640
Amortization of acquisition-related intangibles 85 39 98 118
Change in fair value of contingent consideration 272 0 71 0
Restructuring 1 0 1,328 0
Total operating expenses 8,867 9,101 27,151 28,562
Operating loss (3,851) (4,060) (26,350) (20,554)
Change in fair value of warrants 399 101 1,468 667
Gain on sale of minority interest 0 325 951 325
Interest income (expense), net 49 (89) 94 (331)
Other (expense)/income, net (279) 873 (2,449) 481
Loss before income tax (benefit) expense (3,682) (2,850) (26,286) (19,412)
Income tax (benefit) expense 566 (82) 496 1,036
Net loss $ (4,248) $ (2,768) $ (26,782) $ (20,448)
Net loss per common share        
Basic (in dollars per share) $ (0.21) $ (0.20) $ (1.44) $ (1.49)
Diluted (in dollars per share) $ (0.21) $ (0.20) $ (1.44) $ (1.49)
Weighted average number of common shares outstanding        
Basic (in shares) 19,949 13,792 18,614 13,746
Diluted (in shares) 19,949 13,792 18,614 13,746